Is maternal cannabis exposure associated with increased risk of adverse pregnancy outcomes related to placental function?

Researchers assessed the relationship between maternal cannabis use and adverse pregnancy outcomes linked to placental function.

Replimune kickstarts Phase III melanoma trial studying RP1 immunotherapy – Pharmaceutical Technology

IGNYTE-3 tests the efficacy of RP1 against melanoma when other treatments have failed Replimune has announced the first patient in the Phase III melanoma trial

August 14, 2024

Revolutionizing hepatocyte count for researchers

In this interview, NewsMedical speaks to DeNovix’s Dan Schieffer about the new app developed for CellDrop, and how it aims to revolutionize hepatocyte count for

April 3, 2024

UnitedHealthcare Launches Virtual Eyewear Prescription Renewal

What You Should Know: UnitedHealthcare launches a new virtual eyewear prescription renewal option for millions of members enrolled in eligible employer-sponsored vision plans. Millions of

June 23, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.